Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
This is not a clinical advantage
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) Semaglutide and tirzepatide are examples of GLP-1 RAs, a category of peptides originally developed for diabetes management but found to promote weight loss through their actions on the pancreas and digestion
If a drug is on the formulary, it will be covered
Adems, la tasa metablica basal puede disminuir ligeramente despus de una prdida de peso significativa, lo que reduce el gasto energtico diario
Molecular Characteristics Compound Name: Ipamorelin CAS Number: 170851-70-4 Peptide Length: 5 amino acids Molecular Formula: C38H49N9O5 Molecular Weight: ~711.85 g/mol Form: Lyophilized peptide powder Purity: 99% HPLC verified Stability Profile and Storage Recommendations Store lyophilized peptide at 20C Protect from moisture and light exposure Avoid repeated freezethaw cycles Reconstituted solutions should be refrigerated Use sterile laboratory solvents for preparation Solubility and Reconstitution Options Sterile bacteriostatic water Sterile saline solutions Laboratory buffer solutions Peptide assay buffers Biochemical solvent systems Technical Specifications product Name Ipamorelin 2mg brand BioPeptides cas 170851-70-4 purity 99% (HPLC verified) unit Size 2mg vial form Lyophilized powder synthesis Solid-Phase Peptide Synthesis (SPPS) analytical HPLC and Mass Spectrometry molecular Structure Growth hormone secretagogue peptide stability Stable when stored at 20C Analytical Validation and Quality Assurance High-performance liquid chromatography purity verification Mass spectrometry molecular weight confirmation Peptide structural integrity validation Batch-to-batch analytical consistency testing Peptide stability verification Regulatory and Compliance Statement Ipamorelin supplied by BioPeptides is intended strictly for laboratory and scientific research use only
Insurance may reduce this cost significantly, but coverage varies by plan and medical necessity requirements
